maybe reading the whole announcement will give you a better understanding.
mutually agreed deliverables that "upon execution" will result in a commercial agreement. I don't read that as having a road map !!!
then we have "Why ramp up production without an agreement in place?"
we need to prove that we can supply anteoX at volume with quality assurance before any company would sign a commercial deal. which both are stated will happen this quarter.
and finally with the missed June Kpi about anteobind distribution, we have added Biogenuix (india ) to our website distributors so I disagree that was missed !!!
but as I have said before, each to their own opinion.
maybe reading the whole announcement will give you a better...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $50.57M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $38.09K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1505316 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 676543 | 1 |
View Market Depth
| Last trade - 15.57pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.3¢ | 2.2¢ | 764931 | ||
| Last updated 15.55pm 03/05/2024 ? | |||||
| ADO (ASX) Chart |